Influence of Inhaled Corticosteroids and Dietary Intake on Bone Density and Metabolism in Patients With Moderate to Severe Asthma

Objectives Compare the effect of high doses of inhaled corticosteroids on bone loss in subjects with moderate to severe asthma or mild asthma, and examine the influence of dietary intake on bone metabolism. Design A survey on the effects of corticotherapy and nutrition on bone density was conducted in 74 subjects currently being treated for asthma in the asthma clinic of Hospital Laval (Sainte-Foy, Quebec, Canada). Fifty-eight subjects completed the study (attrition RATE=15%).

Main outcome measures In all subjects expiratory volumes were determined and urinary analysis was conducted for hydroxyproline, calcium, phosphorus, and cortisol levels. Osteocalcin, calcium, phosphorus, cortisol, alkaline phosphatase, and γ-glutamyltransferase levels were measured in blood samples. Bone density of the lumbar spine was determined by means of dual-energy x-ray absorptiometry. Nutrition evaluation was based on a 3-day food diary analyzed using progiciel Nutri 91. The nutritional parameters examined were calcium; phosphorus; magnesium; zinc; vitamins A, C, and D; protein; total fiber; oxalates; energy; caffeine; and alcohol in relation to bone density.

Subjects Thirty-one patients with moderate to severe asthma who had been taking more than 1,000 μg beclomethasone per day or the equivalent for more than 2 years and 27 patients with mild asthma who were taking less than 500 μg beclomethasone per day or the equivalent.

Statistical analyses performed Four factor analysis of variance with hierarchized interactions of four levels, Duncan's test, Pearson correlation coefficients.

Results Blood levels of osteocalcin and protein intake were lower in patients with moderate to severe asthma than in those with mild asthma (P<.05). Significant correlations (P<.02) were observed between bone density and calcium intake (r=.40), phosphorus intake (r=.35), protein intake (r=.30), and serum alkaline phosphatase level (r=−.30). Bone density was not significantly different between the two groups of patients with asthma.

Applications A follow-up of patients with asthma who are taking inhaled corticosteroids is needed to assess bone density, osteocalcin levels, and dietary intakes of calcium. Verify if osteocalcin level decreases over time in patients with moderate to severe asthma, monitor possible modifications in bone density, and verify if the correlation between dietary calcium and bone density is maintained. J Am Diet Assoc. 1997;97:1401–1406.     

Über die Bedeutung der Hauterscheinungen beim akuten Gelenkrheumatismus

Zusammenfassung Die Auffassung des akuten Gelenksrheumatismus als allergische Krankheit bedingt auch die Deutung der diese Erkrankung begleitenden Hauterscheinungen als allergische Phänomene. Das Erythema annulare und die Urticaria rheumatica werden im Sinne toxisch-allergischer Effloreszenzen erklärt, und der Rheumatismus nodosus diesen beiden Hautveränderungen als periphere hyperergische Entzündung bei einer bestimmten Reaktionslage des sensibilisierten Organismus symptomatologisch und prognostisch nahegestellt. An Hand mehrerer Fälle werden Beobachtungen gebracht, daß die erwähnten peripheren Erscheinungen klinisch ähnliches Geschehen begleiten und somit ihre engere innere Verwandtschaft als wahrscheinlich angenommen. Erythema annulare, Urticaria rheumatica und Rheumatismus nodosus begleiten eine Generalisation der rheumatischen Infektion und treten meist dann auf, wenn die Herzklappen, das Nervensystem oder die serösen Häute ergriffen werden. Alle drei Phänomene haben auch gemeinsame Beziehungen zu Allergieschwankungen im Organismus. In diesem Sinne werden die erwähnten Erscheinungen als Symptome eines allergischen Sekundärstadiums der akuten Polyarthritis aufgefaßt (ähnlich den sekundären Hauteffloreszenzen bei der Tuberkulose) und ihnen als Indikatoren der Generalisation der rheumatischen Noxe, besondere prognostische Bedeutung zugemessen.     

Bone Mineral Density Determinations by Dual-Energy x-ray Absorptiometry in the Management of Patients with Marfan Syndrome—Some Factors Which Affect the Measurement

Reduced bone mineral density (BMD) was sporadically reported in patients with Marfan syndrome. This may or may not place the Marfan patient at increased risk for bone fracture. In comparing the BMDs of our patients with those reported in the literature, it seemed that agreement between values, and hence the degree of osteoporosis or osteopenia reported, was dependent on the instrumentation used. The objective of this study was to statistically assess this impression. Bone mineral density measurements from our previously published study of 30 adults with Marfan syndrome performed on a Lunar DPXL machine were compared with studies published between 1993–2000 measured using either Lunar or Hologic bone densitometry instruments. The differences of our measurements compared with those made on other Lunar machines were not statistically significant, but did differ significantly with published results from Hologic machines (P < 0.001). Before progress can be made in the assessment of BMD and fracture risk in Marfan patients and in the evidence-based orthopedic management of these patients, standardization of instrumental bone density determinations will be required along with considerations of height, obesity, age, and sex.